Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best healthcare stocks under $50 to invest in. Barclays ...

Teva beat fourth-quarter estimates as drug sales surged, led by Austedo and Ajovy, while the company forecast steady earnings and revenue growth for 2026.

While some investors are already well versed in financial metrics (hat tip), this article is for those who would ...

Goldman Sachs revealed a slew of stocks that the firm says are extremely compelling. The Wall Street investment bank said ...

Teva Pharmaceutical Industries (TEVA) shares snapped six straight sessions of gains, as the stock closed 0.4% lower at $33.07 on Thursday. The generic drugmaker gained about 6% in the preceding ...

Teva Pharmaceutical Industries operates in the pharmaceuticals sector, where product mix, regulatory milestones, and ...

A jury in Atlanta federal court has sided with Teva Pharmaceuticals in the first trial testing claims the company failed to ...

As the biopharma industry moves into the new year, Teva is looking to put the past behind it. After proposing a blockbuster $4.25 billion opioid settlement, the drugmaker has secured participation ...

Throughout the year, Teva had momentum in innovative medicines, scaling its global generics and biosimilars portfolio.

Teva has issued a voluntary recall of more than 500,000 bottles of the widely used blood pressure medication prazosin hydrochloride, citing unacceptable levels of potentially cancer-causing impurities ...

By Steven Scheer JERUSALEM, Jan 28 (Reuters) - Teva Pharmaceutical Industries reported strong quarterly results on Wednesday but forecast lower net profit and revenue in 2026 on a more than $1 billion ...

Viagra is so popular that its name has become synonymous with ED treatment — just like Ziploc has with plastic bags. But the active ingredient in Viagra is sildenafil. Pfizer Pharmaceuticals patented ...